Cellular entry of the SARS coronavirus
暂无分享,去创建一个
[1] X. L. Liu,et al. Isolation and Characterization of Viruses Related to the SARS Coronavirus from Animals in Southern China , 2003, Science.
[2] D. Dimitrov,et al. A model of the ACE2 structure and function as a SARS-CoV receptor , 2003, Biochemical and Biophysical Research Communications.
[3] D. Dimitrov. The Secret Life of ACE2 as a Receptor for the SARS Virus , 2003, Cell.
[4] W. Thomas,et al. Amino Acids 270 to 510 of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein Are Required for Interaction with Receptor , 2004, Journal of Virology.
[5] K. Subbarao,et al. pH-Dependent Entry of Severe Acute Respiratory Syndrome Coronavirus Is Mediated by the Spike Glycoprotein and Enhanced by Dendritic Cell Transfer through DC-SIGN , 2004, Journal of Virology.
[6] R. Levis,et al. Multiple receptor-dependent steps determine the species specificity of HCV-229E infection. , 1995, Advances in experimental medicine and biology.
[7] Nigel M. Hooper,et al. A Human Homolog of Angiotensin-converting Enzyme , 2000, The Journal of Biological Chemistry.
[8] J. Kilby,et al. Novel therapies based on mechanisms of HIV-1 cell entry. , 2003, The New England journal of medicine.
[9] J. Lepault,et al. Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[10] J. Sung,et al. Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection , 2003, Gastroenterology.
[11] Ari Helenius,et al. How Viruses Enter Animal Cells , 2004, Science.
[12] Saurabh Menon,et al. ACE2 X-Ray Structures Reveal a Large Hinge-bending Motion Important for Inhibitor Binding and Catalysis , 2004, Journal of Biological Chemistry.
[13] M. Enserink. One Year After Outbreak, SARS Virus Yields Some Secrets , 2004, Science.
[14] Christian Drosten,et al. Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome , 2003, Science.
[15] D. Dimitrov,et al. Virus entry: molecular mechanisms and biomedical applications , 2004, Nature Reviews Microbiology.
[16] Malik Peiris,et al. Aetiology: Koch's postulates fulfilled for SARS virus , 2003, Nature.
[17] Gary J. Nabel,et al. A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice , 2004, Nature.
[18] Arul Earnest,et al. Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome. , 2003, JAMA.
[19] Michelle M. Packard,et al. Prior Infection and Passive Transfer of Neutralizing Antibody Prevent Replication of Severe Acute Respiratory Syndrome Coronavirus in the Respiratory Tract of Mice , 2004, Journal of Virology.
[20] J. Peiris,et al. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome , 2003, The Lancet.
[21] R. Hodges,et al. Structural Characterization of the SARS-Coronavirus Spike S Fusion Protein Core , 2004, Journal of Biological Chemistry.
[22] G. Gao,et al. Following the rule: formation of the 6-helix bundle of the fusion core from severe acute respiratory syndrome coronavirus spike protein and identification of potent peptide inhibitors , 2004, Biochemical and Biophysical Research Communications.
[23] Xiaolei Yin,et al. Expression cloning of functional receptor used by SARS coronavirus , 2004, Biochemical and Biophysical Research Communications.
[24] M. Crackower,et al. Angiotensin-converting enzyme 2 is an essential regulator of heart function , 2002, Nature.
[25] M. Buchmeier,et al. Coronavirus Spike Proteins in Viral Entry and Pathogenesis , 2001, Virology.
[26] P. Talbot,et al. Coronavirus Hcov-229e of the Spike Glycoprotein of Human Identification of a Receptor-binding Domain , 2002 .
[27] Obi L. Griffith,et al. The Genome Sequence of the SARS-Associated Coronavirus , 2003, Science.
[28] Xin Li,et al. The clinical pathology of severe acute respiratory syndrome (SARS): a report from China , 2003, The Journal of pathology.
[29] J. A. Comer,et al. A novel coronavirus associated with severe acute respiratory syndrome. , 2003, The New England journal of medicine.
[30] W. Bellini,et al. Effects of a SARS-associated coronavirus vaccine in monkeys , 2003, The Lancet.
[31] A. Steinkasserer,et al. DC-SIGN and DC-SIGNR Interact with the Glycoprotein of Marburg Virus and the S Protein of Severe Acute Respiratory Syndrome Coronavirus , 2004, Journal of Virology.
[32] B. Murphy,et al. An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus , 2004, Nature Medicine.
[33] B. Bosch,et al. The Coronavirus Spike Protein Is a Class I Virus Fusion Protein: Structural and Functional Characterization of the Fusion Core Complex , 2003, Journal of Virology.
[34] Y. Guan,et al. Coronavirus as a possible cause of severe acute respiratory syndrome , 2003, The Lancet.
[35] Y. Guan,et al. Unique and Conserved Features of Genome and Proteome of SARS-coronavirus, an Early Split-off From the Coronavirus Group 2 Lineage , 2003, Journal of Molecular Biology.
[36] B. Delmas,et al. Determinants essential for the transmissible gastroenteritis virus-receptor interaction reside within a domain of aminopeptidase-N that is distinct from the enzymatic site , 1994, Journal of virology.
[37] P S Kim,et al. Mechanisms of viral membrane fusion and its inhibition. , 2001, Annual review of biochemistry.
[38] D. Dimitrov,et al. The SARS-CoV S glycoprotein: expression and functional characterization , 2003, Biochemical and Biophysical Research Communications.
[39] Qingling Zhang,et al. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS‐CoV) in SARS patients: implications for pathogenesis and virus transmission pathways , 2004, The Journal of pathology.
[40] G. Simmons,et al. Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[41] Yi Guan,et al. Lung pathology of fatal severe acute respiratory syndrome , 2003, The Lancet.
[42] A. J. Gibbs,et al. The phylogeny of SARS coronavirus , 2004, Archives of Virology.
[43] Wenhui Li,et al. A 193-Amino Acid Fragment of the SARS Coronavirus S Protein Efficiently Binds Angiotensin-converting Enzyme 2* , 2004, Journal of Biological Chemistry.
[44] B. Bosch,et al. Cleavage Inhibition of the Murine Coronavirus Spike Protein by a Furin-Like Enzyme Affects Cell-Cell but Not Virus-Cell Fusion , 2004, Journal of Virology.
[45] G. Fey,et al. Susceptibility to SARS coronavirus S protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor , 2004, Biochemical and Biophysical Research Communications.
[46] F. Taguchi. The S2 subunit of the murine coronavirus spike protein is not involved in receptor binding , 1995, Journal of virology.
[47] L. Poon,et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia : a prospective study , 2003 .
[48] G. Navis,et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis , 2004, The Journal of pathology.
[49] Christian Drosten,et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. , 2003, The New England journal of medicine.
[50] A. Debnath,et al. Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors , 2004, The Lancet.
[51] M. Raamsman,et al. Retargeting of Coronavirus by Substitution of the Spike Glycoprotein Ectodomain: Crossing the Host Cell Species Barrier , 2000, Journal of Virology.
[52] B. Moss,et al. Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[53] G. Tse,et al. Tissue and cellular tropism of the coronavirus associated with severe acute respiratory syndrome: an in‐situ hybridization study of fatal cases , 2004, The Journal of pathology.
[54] K. Überla,et al. S Protein of Severe Acute Respiratory Syndrome-Associated Coronavirus Mediates Entry into Hepatoma Cell Lines and Is Targeted by Neutralizing Antibodies in Infected Patients , 2004, Journal of Virology.
[55] Y. Kooyk,et al. DC-SIGN: escape mechanism for pathogens , 2003, Nature Reviews Immunology.
[56] Wenhui Li,et al. Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[57] R. Rappuoli,et al. SARS — beginning to understand a new virus , 2003, Nature Reviews Microbiology.
[58] S. Perlman,et al. Pathogenesis of coronavirus-induced infections. Review of pathological and immunological aspects. , 1998, Advances in experimental medicine and biology.
[59] A. Carfi,et al. Structural characterization of the fusion-active complex of severe acute respiratory syndrome (SARS) coronavirus. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[60] B. Berkhout,et al. Identification of a new human coronavirus , 2004, Nature Medicine.
[61] John L. Sullivan,et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus , 2003, Nature.